Top View
- New Expectations in the Treatment of Anemia in Chronic Kidney Disease
- Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
- HIF-Α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: a Comprehensive Review
- Kidney News Is Published by the American Society of Nephrology 1401 H Street, NW, Suite 900, Washington, DC 20005
- ROXADUSTAT) FIBROGEN* Phase II Studies Completed (ND CKD, HD, PD) Phase III Studies Ongoing (ND CKD, HD, PD)
- WALLET CARD2021 Examples of Prohibited and Permitted Substances and Methods Effective Jan
- Update on Randomized Clinical Trials in Anemia of CKD KDIGO Chuan-Ming Hao Division of Nephrology, Huashan Hospital Fudan University DISCLOSURES
- Targeting Iron Metabolism in Drug Discovery and Delivery
- WADA 2018 Prohibited List
- Drug Repurposing Compound Library Plus (96-Well)
- Iron Therapy in Chronic Kidney Disease: Days of Future Past
- Effects of Molidustat in the Treatment of Anemia in Chronic Kidney Disease
- Interpretation of the Kidney Disease: Improving Global Outcomes Guidelines for Iron Therapy: Commentary and Emerging Evidence Jeffrey S
- WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
- Prolyl Hydroxylase Domain Inhibitors: a New Era in the Management of Renal Anemia
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Controversias Sobre El Óptimo Manejo De La Anemia (2021) Descargar Pdf
- Effects of Molidustat in the Treatment of Anemia in CKD
- Drug Repurposing Compound Library (96-Well)
- KDIGO Executive Conclusions
- Dependent Chronic Kidney Disease: Design and Rationale of Two Phase III Studies
- Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
- TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver S
- Review Anemia of Chronic Kidney Disease
- Older Americans Affecting Diseases Chronic Top
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- LPGA Prohibited Substances List
- Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience